| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |